Sebi first began looking into the matter last month.
.jpg)
The company had in May announced that the US Food and Drug Administration had issued an import alert on its Waluj facility, which makes injectables and solid dosages.
Indian pharma firms under European drug regulator's scanner.
Industry is gathering scientific data to approach the regulator, DCGI, for a review of the suspension order.
Swiss drug maker Novartis might face tough action from the country's drug regulator for allegedly giving fake documents while seeking renewal of registration for Tiamulin Hydrogen Fumerate (80 per cent granules), sources said.
Financial shares were among the top Sensex gainers along with auto and pharma shares.
After a detailed scrutiny, fair trade watchdog CCI has suggested Sun Pharma and Ranbaxy to make certain changes in their proposed $4 billion merger deal, including possible divestment of some brands, to address anti-competitive concerns.
As fear grips the world, demand for protective gear used by health care professionals and citizens is on a rise. And, supply disruption from China has opened a window of opportunities for Indian medical device makers.
Triumphalism, premature declaration of victory meant no one checked if India had enough vaccines, oxygen, remdesivir, bringing us back to a crisis where we need foreign aid after four decades, asserts Shekhar Gupta.
After spending considerable time and energy in remediation efforts in the wake of the US Food and Drug Administration's warning letter on compliance issues, the company's leadership has finally set out to bring the house in order.
The drug that it would supply is called Olanzapine, used to treat schizophrenia and bipolar disorder.
MicroPort entered the market on Feb 15 and its stent was used in a Mumbai hospital.
Healthcare, auto and financial stocks lagged.
Import alert on Ranbaxy's Mohali unit; Strides' injectible arm gets warning letter
In his press conference on Wednesday, Trump targeted drug-makers and vowed to bring back production in the US.
A large number of large and small businesses process EU data, have customers from the EU or have access to data of EU citizens in one way or another.
The winter session of Parliament will commence on November 26.
Inspections only in domestic authorities' presence, visiting US drug regulator told
Equity investors should thank cash-rich biggies such as TCS, ITC, HUL, Nestl, and Bajaj Auto for this.
Rating agency Crisil said corporates, especially those in the auto, aviation, consumer durables and oil sectors, will be "severely impacted" by rupee depreciation due to large overseas debt and limited hedging.
n the broader market, both the BSE Midcap and Smallcap indices, were up 1.2% and 0.7% each.
.jpg)
According to market regulator Securities and Exchange Board of India, MF investments in banking stocks reached Rs 48,419 crore (Rs 484.19 billion) as on May 31, accounting for 21.59 per cent of their total equity assets under management (of Rs 2.24 lakh crore or Rs 2.24 trillion).
There were apprehensions in the SII about rival Bharat Biotech's 'indigenous' tag, opening up shortcuts for it. One senior person, who was very familiar with the sector, told me, 'The message has gone out from the very top. Somani (V G Somani -- drug controller general of India) has told me "Bharat ka karna hai".' A fascinating excerpt from Abantika Ghosh's Billions Under Lockdown: The Inside Story Of India's Fight Against COVID-19.
'When there is unlocking, there is demand revival.' 'This is going to be the main growth engine in this kind of an economic scenario.'
NITI Aayog wants the prime minister's flagship initiative should focus on labour-intensive sectors and policies that impede their growth to get special attention.
The plan was activated in October last year.
Contrarian stocks can help investors generate much higher returns than buying shares of companies that have shown consistent high growth for years.
The next hearing on Pfizer's plea is slated for March 21
Popular antacid Mucaine Gel, manufactured by Pfizer's subsidiary Wyeth Laboratories, was also found laced with the heavy metals as well as cadmium.
All of Ranbaxy's India-based factories are currently banned by the FDA from exporting medicines to the United States, the company's largest market, after the regulator's inspection found violation of its so-called good manufacturing practices.
Sun Pharma's market capitalisation stood at Rs 100,050 crore on December 5, with its share price closing at Rs 417 a piece - lowest since March 2013.
Dilip Shanghvi founded Sun Pharma in 1983.
The capital market regulator has to recover Rs 64.85 lakh (Rs 6.48 million) from Ranbaxy's former independent director V K Kaul and Rs 12.97 lakh (Rs 1.29 million) from his wife Bala Kaul.
'The coronavirus epidemic highlights the need to start thinking more actively about multilateral coordination, including, but not confined to, health emergencies and climate uncertainties,' says Rathin Roy.
She also suggested exploring the possibility of setting up de-addiction centres near these railway stations.
'As for tricky relations with China, India needs less of summitry type event management and more anticipatory analysis and management of events,' says Ambassador Jaimini Bhagwati.
Legal experts and official sources said the alleged submission of fake documents can also lead to criminal charges against Novartis.
The company buys distressed assets across the globe and turns them around to not only add to its books but also its product pipeline and regions.
A probe finds several pharma majors in breach of the law; and in turn they blame the government.
'If she contests it, then these people will have to fight it in court.'
